AMENDMENT No. 2 TO CLINICAL SUPPLY AND COOPERATION AGREEMENTClinical Supply and Cooperation Agreement • November 10th, 2015 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment to the Clinical Supply and Cooperation Agreement (this “Amendment”) dated as of July 22, 2015 is by and between Ritter Pharmaceuticals, Inc., a Delaware corporation (“Ritter”) and Ricerche Sperimentali Montale SpA, an Italian company (“Ricerche”) and Inalco SpA, a Italian company (“Inalco”, together with Ricerche, “RSM”).
AMENDMENT 1 To the Clinical Supply and Cooperation Agreement (hereinafter “CSCA”) entered into between:Clinical Supply and Cooperation Agreement • April 24th, 2015 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations
Ritter Pharmaceuticals, Inc., a Delaware corporation, with registered offices at 1880 Century Park East #1100, Los Angeles, CA 90067, (hereinafter “Ritter”)
Clinical Supply and Cooperation Agreement Between Ritter & RSM/Inalco CLINICAL SUPPLY AND COOPERATION AGREEMENT (also referred to as “CSCA”) BETWEENClinical Supply and Cooperation Agreement • April 24th, 2015 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Ø RITTER Pharmaceuticals, Inc. a Delaware Corporation, with registered offices on 10100 Santa Monica Blvd. 42430, Los Angeles, CA 90067, hereinafter referred to as “RITTER”)
